Market Cap (In INR)
5.67 Billion
Revenue (In INR)
1.41 Billion
Net Income (In INR)
259.77 Million
Avg. Volume
4233.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 243.2-1325.0
- PE
- -
- EPS
- -
- Beta Value
- 0.9343063
- ISIN
- INE354A01013
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Ashish Uttam Bhuta
- Employee Count
- -
- Website
- http://www.jenburkt.com
- Ipo Date
- 2000-11-27
- Details
- Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. It operates through the following segments: Local and Exports. The company was founded by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta and Harshad N. Bhuta on June 10, 1985 and is headquartered in Mumbai, India.
More Stocks
-
OVHOVH Groupe S.A.
OVH
-
LQRLQR House Inc.
LQR
-
MINALINDMINAL INDUSTRIES LIMITED
MINALIND
-
AESB3AES Brasil Energia S.A.
AESB3
-
INANISECInani Securities Limited
INANISEC
-
UMESLTD
-
MIDINDIAMid India Industries Limited
MIDINDIA
-
RISAINTLRisa International Limited
RISAINTL